Skip to main content Skip to page footer

Prof. Dr. Dr. Eva Winkler

Managing Director NCT Heidelberg
Head of Section Translational Medical Ethics (previously: Ethics and Patient Orientation in Oncology (NCT-EPOC))
Vice-Chair of the German Ethics Council
Chair of ZEKO, Vice-President of AEM

Phone: +49 6221 56-36049
E-mail: Eva.Winkler(at)med.uni-heidelberg.de

Eva Winkler is an oncologist and Professor for Translational Medical Ethics (previously Heisenberg-Professorship) at Heidelberg University. She heads the Section for Translational Medical Ethics. The section covers the entire range of ethical questions relating to the translation of research results into healthcare. Professor Winkler is a specialist in haematology/oncology and works as a senior physician in the Department of Medical Oncology at the UKHD. 

She received her doctorate in cancer research from Heidelberg University / DKFZ and in medical and health ethics from the University of Basel (Switzerland). She also received her medical-ethical training as part of two fellowships in the Department of Medical Ethics at Harvard Medical School and as a faculty fellow at the Center for Ethics and the Professions at Harvard University/Kennedy School of Government. The main research areas of her section are: research ethics, clinical ethics and public health ethics. Eva Winkler is the scientific director and spokesperson for EURAT (interdisciplinary platform for Ethical and Legal Issues of Translational Medicine). She is also the Chair of the Central Ethics Committee (ZEKO) of the Bundesärztekammer (BÄK), Vice-President of the medical ethics association „Academy for Ethics in Medicine“ (AEM), and Member and Vice-Chair of the German Ethics Council.

Professional background – medical ethicist

Since 2024
Professorship for Translational Medical Ethics

2012-2020
Head of Clinical Cancer Program Neuroendocrine Tumors

2019-2024
Heisenberg-Professorship for Translational Medical Ethics 

2013/2019
Fellow at the Marsilius Kolleg

Since 2012
Spokesperson of the EURAT group

2011-19
Head of the working group on Ethics and Patient Orientation at NCT Heidelberg

2006-10
Doctoral studies in medicine and health ethics, University of Basel

2004-10
Project management ethics at the Medical Clinic III of the LMU Munich

2002-04
Fellowship: Department of Medical Ethics, Harvard Medical School
Fellowship: Center for Ethics and the Professions, Kennedy School of Government, Harvard University and Massachusetts General Hospital (sponsored by Harvard)

1991-92
Foundation for political and Christian youth education e.V., assistant to the board

Professional background – specialist in hematology and oncology

2016
Specialist in hematology/oncology and additional qualification in palliative medicine

2012-2020
Head of Clinical Cancer Program Neuroendocrine Tumors

Since 2012
Senior Physician at NCT Heidelberg

2011
Specialist in internal medicine

2000-2010
Specialist training, Medical Clinic III (hematology/oncology), Klinikum Großhadern, LMU Munich

Since 2012
Spokesperson of the EURAT group

Since 2025
Vice Dean for Digitalization

Since 2024
Professorship for Translational Medical Ethics

2019-2024
Heisenberg-Professorship

Until 2019
Associate Professor (“Außerplanmäßige Professur”), Medical Faculty Heidelberg

2012
"Umhabilitation", University of Heidelberg

2011
Assistant Professor (“Habilitation”), internal medicine/medical ethics; LMU Munich

2006-10
Doctor of Philosophy (“Promotion”), Dr. phil. (medical and health ethics), University of Basel (s.c.l)

1994-2000
Doctor of Medicine (“Promotion”), University of Heidelberg/DKFZ (c.l.)

2016
Lohfert Prize for Patient Safety and Patient Communication

2010
Faculty award from the University of Basel for the best doctoral thesis

1996-99
Promotion of young journalists, Konrad-Adenauer-Foundation

Since 2024
Member and Vice-Chair of the German Ethics Council

Since 2023
Chair of ZEKO (Central Ethics Committee of the  Bundesärztekammer) (since 2020 Member and board of directors)

Since 2023
Leopoldina-AG „Framework for clinical trials on vulnerable people“

Since 2022
Vice-President of the Academy for Ethics in Medicine (AEM) (Since 2016 Member of the Executive Board)

Since 2020
Board of Directors of the NFDI Consortium “The German Human Genome-Phenome Archive” (GHGA)

Since 2020
Member of the Interdisciplinary Working Group “Gene technology report” at Berlin Institute of Health (BIH) (until 2022 at the Berlin Brandenburg Academy of Science)

Since 2019
AG Consent – Medical Informatics Initiative (MII)

Since 2009
Working Group on Medicine and Ethics, DGHO